No skullduggery involved in pharma equiry submission switch says EPO
On Monday, the IP Kat blog ran a worrying story about apparent changes to the European Patent Office's submission to the DG Compeition's on-going enquiry into the pharmaceutical sector. IP Kat co-author Jeremy Phillips, who many of you will…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.